AMGN compared with RVMD: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

RVMDRevolution Medicines, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

RVMDRevolution Medicines, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

RVMD2 of 4 reports

1 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.7%▼−11.04%×1.13

Q2 FY26±7.9%▲+0.26%×0.04

= impliedAMGN realized, solidRVMD realized, hatchedOne scale, both sides: full bar = 12%× = |realized| ÷ impliedspan: AMGN 273d · RVMD 91dSource: market data

AMGNAmgen Inc

460.55▲+0.06%· post 460.34· delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

RVMDRevolution Medicines, Inc.

192.54▲+8.38%· post 192.56· delayed

After hoursNov 6 '26delayed

Mkt cap$38.4BRevenue$198MQ3 FY26Revenue—

Compare

After hoursNov 6 '26delayed

AMGNAmgen Inc

RVMDRevolution Medicines, Inc.

460.55▲+0.06%post 460.34delayed

Price

192.54▲+8.38%post 192.56delayed

$249.0B

Mkt cap

$38.4B

Q3 FY26$10.4B

Revenue

$198MQ3 FY26

FY25$36.8B

Revenue

—

AMGN460.55▲+0.06%vsRVMD192.54▲+8.38%After hoursNov 6 '26delayed